61
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials

, , , , , & show all
Pages 189-201 | Published online: 08 Jan 2018

References

  • ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc20085454955518453370
  • JacksonMLNeuzilKMThompsonWWThe burden of community-acquired pneumonia in seniors: results of a population-based studyClin Infect Dis200439111642165015578365
  • CurcioDCanéAIsturizRRedefining risk categories for pneumococcal disease in adults: critical analysis of the evidenceInt J Infect Dis201537303525997673
  • TorresABlasiFDartoisNAkovaMWhich individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseThorax2015701098498926219979
  • CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
  • MüllerovaHChigboCHaganGWThe natural history of community-acquired pneumonia in COPD patients: a population data-base analysisRespir Med201210681124113322621820
  • ManninoDMDavisKJKiriVAChronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohortRespir Med2009103222422918945605
  • RestrepoMIMortensenEMPughJAAnzuetoACOPD is associated with increased mortality in patients with community-acquired pneumoniaEur Respir J200628234635116611653
  • DiSantostefanoRLLiHHindsDGalkinDVRubinDBRisk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysisInt J Chron Obstruct Pulmon Dis2014945746824855350
  • DiBardinoDBWunderinkRGAspiration pneumonia: a review of modern trendsJ Crit Care2015301404825129577
  • van KaamAHLachmannRAHertingEReducing atelectasis attenuates bacterial growth and translocation in experimental pneumoniaAm J Respir Crit Care Med200416991046105314977624
  • KwonKYMyersJLSwensenSJColbyTVMiddle lobe syndrome: a clinicopathological study of 21 patientsHum Pathol19952633023077890282
  • KnowlesMRBoucherRCMucus clearance as a primary innate defense mechanism for mammalian airwaysJ Clin Invest2002109557157711877463
  • Terheggen-LagroSTruijensNvan PoppelNGulmansVvan der LaagJvan der EntCCorrelation of six different cystic fibrosis chest radiograph scoring systems with clinical parametersPediatr Pulmonol200335644144512746940
  • DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
  • FishmanAMartinezFNaunheimKNational Emphysema Treatment Trial Research GroupA randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaN Engl J Med2003348212059207312759479
  • PalayewMJThe tracheal-esophageal stripe and the posterior tracheal bandRadiology197913211113451182
  • CasanovaCBaudetJSdel Valle VelascoMIncreased gastrooesophageal reflux disease in patients with severe COPDEur Resp J2004236841845